Table IV.
Recurrent Rare CNVs in TS Cases with Left-Sided Lesions
Region | Type | Candidate Genes | Disease Gene | Animal Model | Prior CHD | Network | Total |
---|---|---|---|---|---|---|---|
7p15.2 | Del | HOXA3,HOXA4,HOXA5,HOXA6,HOXA7,EVX1,HOXA9,HOXA10,HOXA11,HOXA13,HOTTIP | 1 | 1 | 0 | 1 | 3 |
21q21.1 | Dup*/Del | CXADR,BTG3 | 0 | 1 | 1 | 0 | 2 |
13q12.11 | Dup* | ZMYM2,ZMYM5, GJA3,GJB6 | 0 | 0 | 1 | 1 | 2 |
18p11.32 | Del | COLEC12,CETN1,CLUL1,C18ORF56,TYMS | 0 | 1 | 1 | 0 | 2 |
1q43 | Dup*/Del | FH,KMO,WDR64,OPN3,CHML,PLD5 | 0 | 0 | 1 | 0 | 1 |
4q32.3 | Dup*/Del | TRIM60,TRIM61,TMEM192 | 0 | 0 | 0 | 0 | 0 |
Lists of candidate CNV regions ranked by prioritization scores. Region: in hg19 coordinates; Dup: duplication
disrupting duplication
Del: deletion; Disease Gene: mutations identified in subjects with congenital heart defects; Animal model: targeted disruption causes aortic and/or cardiac phenotypes; Prior CHD: CNVs discovered in subjects with congenital heart disease; Network: in top 10% of genes identified by ToppGene analysis using known BAV and TAAD genes as seeds.